$277.46
3.30%
Nasdaq, Oct 15, 04:40 pm EDT. Closed.
Why the stock moved Why the stock moved Beta

Lam Research Target price 2026 - Analyst rating & recommendation

Lam Research Classifications & Recommendation

Buy
85%
Hold
15%

Lam Research Price Target

Target Price $387.60
Price $277.46
Potential 39.70%
Number of Estimates 34
34 Analysts have issued a price target Lam Research 2027 . The average Lam Research target price is $387.60. This is 39.70% higher than the current stock price. The highest price target is $525.00 89.22% , the lowest is $215.13 22.46% .
A rating was issued by 41 analysts: 35 Analysts recommend Lam Research to buy, 6 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Lam Research stock has an average upside potential 2027 of 39.70% . Most analysts recommend the Lam Research stock at Purchase.

Sales and Margin forecast 2027, 2028 to 2031

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Jun '26 2027
Estimates
Revenue Billion $ ??? ???
??? ???
EBITDA Margin ??? ???
??? ???
Net Margin ??? ???
??? ???

37 Analysts have issued a sales forecast Lam Research 2027 . The average Lam Research sales estimate is

. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .

This results in the following potential growth metrics:

Revenue Estimates

2026 $23.2b 26.02%
2027
2028
2029
2030
2031

25 Analysts have issued an Lam Research EBITDA forecast 2027. The average Lam Research EBITDA estimate is

. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2026 $8.6b 37.44%
2027
2028
2029
2030
2031

EBITDA Margin

2026 37.19% 9.06%
2027
2028
2029
2030
2031

37 Lam Research Analysts have issued a net profit forecast 2027. The average Lam Research net profit estimate is

. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2026 $7.3b 35.59%
2027
2028
2029
2030
2031

Net Margin

2026 31.27% 7.60%
2027
2028
2029
2030
2031

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2031

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Jun '26 2027
Estimates
Earnings Per Share $ ??? ???
??? ???
P/E ???
EV/Sales ???

37 Analysts have issued a Lam Research forecast for earnings per share. The average Lam Research EPS is

. This is than earnings per share in the financial year 2026. The highest EPS forecast is , the lowest is .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2026 $5.76 38.80%
2027
2028
2029
2030
2031

P/E ratio

Current 49.64 58.33%
2027
2028
2029
2030
2031

Based on analysts' sales estimates for 2027, the Lam Research stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 15.38 73.20%
2027
2028
2029
2030
2031

P/S ratio

Current 15.45 71.99%
2027
2028
2029
2030
2031

Current Lam Research Upgrades & Downgrades

Analyst Rating Action Date
Morgan Stanley
Overweight
➜
Overweight
Unchanged Oct 05 2026
B. Riley Securities
Buy
➜
Buy
Unchanged Oct 01 2026
UBS
Buy
➜
Buy
Unchanged Sep 01 2026
Mizuho
Outperform
➜
Outperform
Unchanged Aug 25 2026
Morgan Stanley
Overweight
➜
Overweight
Unchanged Jul 30 2026
B. Riley Securities
Buy
➜
Buy
Unchanged Jul 30 2026
Jefferies
Buy
➜
Buy
Unchanged Jul 30 2026
Analyst Rating Date
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
Oct 05 2026
Unchanged
B. Riley Securities:
Buy
➜
Buy
Oct 01 2026
Unchanged
UBS:
Buy
➜
Buy
Sep 01 2026
Unchanged
Mizuho:
Outperform
➜
Outperform
Aug 25 2026
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
Jul 30 2026
Unchanged
B. Riley Securities:
Buy
➜
Buy
Jul 30 2026
Unchanged
Jefferies:
Buy
➜
Buy
Jul 30 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today